Medicine Safety
When it comes to medicines, safety has many meanings and many stakeholders: Volunteers in clinical trials, researchers and technicians working in laboratories and manufacturing facilities, regulators at the Food and Drug Administration (FDA), physicians prescribing medicines, and patients who rely on those therapies to lead healthier, longer lives—all have vested interests in drug safety. The safety and integrity of medicines is critical to America’s biopharmaceutical industry and the patients we serve. Learn more about the key medical safety issues facing our industry today.
For a Healthier U.S.: Methods to Fight Prescription Abuse
80% of counterfeit drugs are produced overseas
Latest From The Blog
blog url
ICYMI: Huntsville’s biopharma ecosystem is poised for growth
November 2, 2026
PhRMA to USTR: Use trade policy to defend American innovation
November 2, 2026
The $1.74 trillion sector powering America’s economy
October 29, 2026
How the biosimilars user fee program supports competition and patients
October 26, 2026
Houston’s clinical research ecosystem is building momentum
October 21, 2026
Why 340B needs an itemized bill
October 20, 2026
How the Vaccines for Children program protects America's kids
October 14, 2026
Recognizing the transformative impact of intellectual property
October 13, 2026
Employers faced $12.8 billion in higher costs due to 340B in 2025
October 5, 2026